Austedo XR 36 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26FFG8E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,494
Award facts
- Contract value 100% obligated
- $34,493.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Austedo XR 36 mg tablets (30-count units) with a ceiling value of $34,493.65. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by November 21, 2025. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to meet competitive procurement requirements across diverse therapeutic domains, including neurological treatments, pain management, diabetes medications, antibiotics, vaccines, and specialized medical supplies. Austedo XR is a vesicular monoamine transporter 2 inhibitor used to treat tardive dyskinesia, reflecting the company's role in supplying specialized neurological medications to support military and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FFG8E?
SPE2DR26FFG8E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26FFG8E worth?
The government has obligated $34,494 on SPE2DR26FFG8E.
Is contract SPE2DR26FFG8E an order under another contract?
Yes. SPE2DR26FFG8E is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFG8E competed?
The extent of competition for SPE2DR26FFG8E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award